Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProspeCtive, muLti-site, Single-group, Open-lAbel Study to Evaluate the Safety and Performance of RADSAFE® Inks for radiaTion therapY Site Marking (CLARITY Study)

NCT06854263 is registered in ClinicalTrials.gov with Laboratoires BIOTIC Phocea as lead sponsor.

NCT NCT06854263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06854263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProspeCtive, muLti-site, Single-group, Open-lAbel Study to Evaluate the Safety and Performance of RADSAFE® Inks for radiaTion therapY Site Marking (CLARITY Study)
Lead sponsor
Laboratoires BIOTIC Phocea
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2025
Enrollment
119 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

radiation therapy